Comparison between Chandra Bhagat Pharma IPO and Janus IPO.
IPO Details
Chandra Bhagat Pharma IPO is a SME Fixed Price IPO proposed to list at BSE SME while Janus IPO is a SME Fixed Price proposed to list at BSE SME.
Issue Size and Price
The total issue size of Chandra Bhagat Pharma IPO is up to ₹9.69 Cr whereas the issue size of the Janus IPO is up to ₹7.59 Cr. The final issue price of Chandra Bhagat Pharma IPO is ₹51.00 per share and of Janus IPO is ₹50.00 per share.
IPO Timetable
Chandra Bhagat Pharma IPO opens on Jan 31, 2020, while Janus IPO opens on Jan 27, 2020. The closing date of Chandra Bhagat Pharma IPO and Janus IPO is Feb 06, 2020, and Jan 30, 2020, respectively.
| | Chandra Bhagat Pharma IPO | Janus IPO |
|---|
| Issue Open | Jan 31, 2020 | Jan 27, 2020 |
| Issue Close | Feb 06, 2020 | Jan 30, 2020 |
| Basis Of Allotment (Tentative) | Feb 11, 2020 | Feb 04, 2020 |
| Initiation of Refunds (Tentative) | Feb 13, 2020 | Feb 05, 2020 |
| Credit of Share (Tentative) | Feb 13, 2020 | Feb 06, 2020 |
| Listing date (Tentative) | Feb 14, 2020 | Feb 06, 2020 |
Financials & KPIs
Chandra Bhagat Pharma IPO P/E ratio is 51, as compared to Janus IPO P/E ratio of 57.
Shares Offered
In the Chandra Bhagat Pharma IPO Retail Individual Investors (RII) are offered 9,50,000 shares while in Janus IPO retail investors are offered 9,50,000 shares. Qualified Institutional Buyers (QIB) are offered in Chandra Bhagat Pharma IPO and in Janus IPO.
| | Chandra Bhagat Pharma IPO | Janus IPO |
|---|
| Market Maker Reservation | 1,00,000 shares | 81,000 shares |
| NII | 9,50,000 shares | 7,59,000 shares |
| RII | 9,50,000 shares | 7,59,000 shares |
| Total | 19,00,000 shares | 15,18,000 shares |
Bids Received (Subscription)
Chandra Bhagat Pharma IPO subscribed 1.65x in total, whereas Janus IPO subscribed 1.26x.
